Table 5 |
|||||
|
Preferred antihypertensive agents based on subclinical organ damage, clinical events and comorbid conditions [6] |
|||||
|
ARBs |
ACE inhibitors |
CCBs |
Diuretics |
β-blockers |
|
|
|
|||||
|
Uncomplicated hypertension |
+ |
+ |
+ |
+ |
- |
|
|
|||||
|
Renal dysfunction |
+ |
+ |
- |
- |
- |
|
|
|||||
|
ESRD/proteinuria |
+ |
+ |
- |
Loop diuretics |
- |
|
|
|||||
|
Metabolic syndrome |
+ |
+ |
+ |
- |
- |
|
|
|||||
|
Diabetes mellitus |
+ |
+ |
- |
- |
- |
|
|
|||||
|
Isolated systolic hypertension in the elderly |
- |
- |
+ |
+ |
- |
|
|
|||||
|
Abbreviations: ACE = angiotensin-converting enzyme; ARBs = angiotensin II receptor blockers; CCBs = calcium channel blockers; ESRD = end-stage renal disease. |
|||||
|
Mallat Cardiovascular Diabetology 2012 11:32 doi:10.1186/1475-2840-11-32 |
|||||
